STOCK TITAN

Goldenwell Biotech CEO gifts 20M shares to Ming Zhou

Ming Zhou reports sole voting and dispositive power over the 20,000,000 shares she directly owns.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Goldenwell Biotech, Inc. has a newly reported beneficial owner: Ming Zhou received a gift of 20,000,000 common shares from Chief Executive Officer Shuang Liu on October 8, 2026, representing approximately 20.2% of the issuer’s common stock. Zhou was appointed a director that day. Goldenwell had 99,000,000 common shares issued and outstanding as of August 11, 2026.

Zhou says she holds the shares for investment purposes and may seek additional shares through open-market purchases if the stock is traded in the future, private transactions, or other means. She also reserves the right to dispose of shares and reports no present plan or proposal for the specified corporate or capital-structure actions.

Shares gifted to Ming Zhou 20,000,000 common shares Gifted by Shuang Liu on October 8, 2026
Beneficial ownership Approximately 20.2% Ming Zhou’s reported ownership of Goldenwell Biotech common stock
Common shares issued and outstanding 99,000,000 shares As of August 11, 2026
beneficially owned regulatory
"beneficially owned, in the aggregate, 20,000,000 shares of common stock"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power regulatory
"Sole Voting Power 20,000,000.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 20,000,000.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GWLL shares does Ming Zhou own?

Ming Zhou directly owns 20,000,000 common shares, representing approximately 20.2% of Goldenwell Biotech’s common stock. The issuer had 99,000,000 common shares issued and outstanding as of August 11, 2026.

Who gave Ming Zhou her GWLL shares?

Chief Executive Officer Shuang Liu gifted Ming Zhou 20,000,000 common shares on October 8, 2026. Zhou was appointed a director of Goldenwell Biotech that day.

Does Ming Zhou plan to change her GWLL investment?

Zhou says she holds the shares for investment purposes and may seek additional shares through open-market purchases if Goldenwell’s stock is traded in the future, or through private transactions. She also reserves the right to dispose of shares and reports no present plan or proposal for the specified corporate or capital-structure actions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





38138N104

(CUSIP Number)
Thomas E. Puzzo, Esq.
3823 44th Ave. NE,
Seattle, WA, 98105
206-522-2256

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/08/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D


Ming Zhou
Signature:/s/ Ming Zhou
Name/Title:Ming Zhou
Date:10/08/2026

Keep reading